ATE390919T1 - Trockenpulver mit levothyroxin-natrium mit verabreichung über einen inhalator - Google Patents

Trockenpulver mit levothyroxin-natrium mit verabreichung über einen inhalator

Info

Publication number
ATE390919T1
ATE390919T1 AT04798720T AT04798720T ATE390919T1 AT E390919 T1 ATE390919 T1 AT E390919T1 AT 04798720 T AT04798720 T AT 04798720T AT 04798720 T AT04798720 T AT 04798720T AT E390919 T1 ATE390919 T1 AT E390919T1
Authority
AT
Austria
Prior art keywords
dry powder
inhaler
levothyroxine sodium
administered via
sodium administered
Prior art date
Application number
AT04798720T
Other languages
English (en)
Inventor
Ioulia Tseti
Original Assignee
Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa filed Critical Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa
Application granted granted Critical
Publication of ATE390919T1 publication Critical patent/ATE390919T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04798720T 2004-11-18 2004-11-18 Trockenpulver mit levothyroxin-natrium mit verabreichung über einen inhalator ATE390919T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GR2004/000055 WO2006054120A1 (en) 2004-11-18 2004-11-18 Dry powder comprising levothyroxine sodium administered via inhalator

Publications (1)

Publication Number Publication Date
ATE390919T1 true ATE390919T1 (de) 2008-04-15

Family

ID=34959179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04798720T ATE390919T1 (de) 2004-11-18 2004-11-18 Trockenpulver mit levothyroxin-natrium mit verabreichung über einen inhalator

Country Status (13)

Country Link
US (1) US8333192B2 (de)
EP (1) EP1811987B1 (de)
AT (1) ATE390919T1 (de)
CY (1) CY1107972T1 (de)
DE (1) DE602004012904T2 (de)
DK (1) DK1811987T3 (de)
ES (1) ES2304631T3 (de)
HR (1) HRP20080261T3 (de)
PL (1) PL1811987T3 (de)
PT (1) PT1811987E (de)
RS (1) RS50582B (de)
SI (1) SI1811987T1 (de)
WO (1) WO2006054120A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016218604A1 (de) * 2016-09-27 2018-03-29 Constantin Adams Partikuläres Stoffgemisch, vorzugsweise zur Verwendung bei der Prophylaxe und/oder Behandlung einer Atemwegsstörung
US20200046664A1 (en) 2016-10-10 2020-02-13 Ftf Pharma Private Limited Method for preparation of liquid oral composition of l-thyroxin
EP3644983B1 (de) 2017-06-29 2023-10-25 Yale University Zusammensetzungen und verfahren zur behandlung oder prävention von fibrotischen lungenerkrankungen
WO2019200274A1 (en) 2018-04-12 2019-10-17 MatRx Therapeutics Corporation Compositions and methods for treating elastic fiber breakdown
SI3781126T1 (sl) * 2018-04-16 2022-10-28 Ioulia Tseti Farmacevtska sestava suhih praškov za inhalacijo, ki vsebujejo ščitnični hormon

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE461013B (sv) * 1988-02-11 1989-12-18 Christian Wesslau Farmaceutisk komposition verksam mot lungobstruktioner bestaaende av en betaadrenerg antagonist och ett tyroideahormon
EP0466909B1 (de) * 1990-02-05 1995-06-28 British Technology Group (Usa) Incorporated Schilddrüsenhormone zur kardialen behandlung
US5161524A (en) 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
DE19821625C1 (de) 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
GB9827200D0 (en) * 1998-12-11 1999-02-03 Glaxo Group Ltd Dry powder inhaler
US6645526B2 (en) * 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
GR1004350B (el) 2002-03-29 2003-09-26 Συσκευη εισπνοων ξηρης σκονης

Also Published As

Publication number Publication date
WO2006054120A1 (en) 2006-05-26
DE602004012904T2 (de) 2009-04-16
PL1811987T3 (pl) 2008-08-29
RS50582B (sr) 2010-05-07
US20080178870A1 (en) 2008-07-31
SI1811987T1 (sl) 2008-08-31
ES2304631T3 (es) 2008-10-16
DE602004012904D1 (de) 2008-05-15
HRP20080261T3 (hr) 2008-09-30
DK1811987T3 (da) 2008-07-14
CY1107972T1 (el) 2013-09-04
PT1811987E (pt) 2008-05-26
EP1811987B1 (de) 2008-04-02
US8333192B2 (en) 2012-12-18
EP1811987A1 (de) 2007-08-01

Similar Documents

Publication Publication Date Title
ATE418351T1 (de) Injektionsvorrichtung
NZ594105A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
DE602005024241D1 (de) Inhalator für pulverförmige zubereitungen
JO3323B1 (ar) صور جرعة صيدلانية
EA201300246A1 (ru) Ингибиторы тирозинкиназы брутона
UA95506C2 (uk) Інгаляційний пристрій для медикаментів у порошковій формі
MX2014009765A (es) Dispositivo suplementario para la conexion a un dispositivo de inyeccion.
NZ702801A (en) Treatment of sanfilippo syndrome type b
NZ702808A (en) Methods and compositions for cns delivery of iduronate-2-sulfatase
TNSN07020A1 (en) Her2 antibody composition
IL190838A0 (en) Intranasal administration of rapid acting insulin
UA99656C2 (en) Powder inhaler
TWD136015S1 (zh) 攝影機
MX2009011191A (es) Jeringa ergonomica.
TW200744568A (en) Epinephrine dosing regimens
CY1107972T1 (el) Ξηρα κονiς περιεχουσα νατριουχο λαιβοθυροξινη χορηγουμενη μεσω εκνεφωτη
PH12012501150A1 (en) Nutritional compositions and methods for optimizing dietary acid-base potential
CY1112158T1 (el) Yπoδoxeaς γia xophγoymena yγpa φapmaka
TWD130627S1 (zh) 媒體播放器
BRPI0508549A (pt) inalador de pó seco de dose unica
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
EA200601759A1 (ru) Композиции рамиприла
WO2006071844A3 (en) Oxygen-impervious packaging and methods for storing thyroid hormone
ZA200506992B (en) Fibrate tablet and method for the production thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1811987

Country of ref document: EP